Research article · 2019
Conference abstractPublished 1 Sep 2015
Population pharmacokinetic modeling of Qishe pill in three major TCM-defined constitutional types of healthy Chinese subjects: Study protocol for a phase-I clinical trial
Shanghai University of Traditional Chinese Medicine, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: With the greatly increased morbidity of neck pain, it brought a large challenge to some optimal therapies for various situations in population at a given time based on their demographic, physiological and pathological characteristics. Based on the YQHYTL formula, Qishe Pill (Shanghai Sundise Traditional Chinese Medicine Co., Ltd, China) has been developed and spread in use into clinical settings in 2009. As individualization has become the trend of modern medicine, a personalized medicine of Qishe Pill should be documented and practiced with various patients according to the ancient TCM system, a classification of personalized constitution type, which has been established to determine predisposition and prognosis to diseases as well as therapy and life-style administration. Objective: Therefore, we describe the population pharmacokinetic profile of Qishe Pill and compare its extent of metabolism in the 3 major constitution types (Qi-Deficiency, Yin-Deficiency and Blood-Stasis) to address major challenges of individualized and standardized Traditional Chinese Medicine into clinical practice. Methods: Healthy subject cohorts (N=108) with an emphasis on constitutional types are being established following a standardized pharmacokinetic protocol for the assessment of demographic, physiological, pathological information, laboratory biomarkers, and the collection of blood samples for the PK analysis and second-generation gene sequencing. In the single-dose administration stage, subjects in each constitutional type cohort (N=36) will be randomly divided into three groups with three different doses of Qishe Pill (3.75, 7.5 and 15 grams) relatively. Conclusion: Comparing with the general background population as characterized, a systematic population pharmacokinetic (Pop PK) model for Qishe Pill will be established and verified. Ethical research projects on informed consent procedures and reporting of incidental findings will be launched in parallel.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 30 Apr 2018
Population Pharmacokinetics of Sirolimus in Healthy Chinese Subjects
Conference abstract
Bioequivalence and pharmacokinetic profiles of abiraterone acetate 250-mg tablets in healthy Chinese subjects under fasted and fed condition: A four-way replicate crossover study by a RSABE approach
Short communication · 30 Nov 2019
Diet-induced Alterations in Pharmacokinetics of Cefuroxime Axetil in Healthy Chinese Subjects
Research article · 2016
An Assessment of the Pharmacokinetics and Tolerability of Single-Ascending Doses of Desvenlafaxine Administered to Healthy Chinese Subjects
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Yue-Li Sun”
